Global Filters




Tiers


Species


Attribution

Filter by Tier
Filter by Species
Filter by Attributions
like "mouse, Ap3m2, alcohol"

Returning 36 results: Page 1 of 2


Tier Species Size Attr. GeneSet
Tier I 8175 GS123916: Aflatoxin B1 interacting with Homo sapiens associated genes (MeSH:D016604) in CTD
Tier I 9154 GS202415: GO:0044710 single-organism metabolic process
Tier I 17 GS230195: MSigDB Geneset - chr3p23
Tier I 1854 GS251956: C646 compound interacting with Homo sapiens associated genes (MeSH:C584509) in CTD
Tier I 1854 GS251957: 3-(2-benzyloxyphenyl)-5-chloromethylisoxazole interacting with nan associated genes (MeSH:C584469) in CTD
Tier I 30 GS269783: GWAS Catalog Data for periodontitis in 93 European ancestry cases, 83 European ancestry individuals, 497 European ancestry controls
Tier I 592 GS270085: GWAS Catalog Data for schizophrenia in 592 Ashkenazi Jewish ancestry cases, 505 Ashkenazi Jewish ancestry controls, 36,989 cases, 113,075 controls
Tier IV 399 GS403355: Genes downregulated in blood of children with COVID-19 versus MIS-C
Tier IV 9412 GS404756: Up regulated genes from caudate nucleus (from dorsal striatum) from postmortem human brain tissue with Alcohol Use Disorder (AUD)
Tier IV 8883 GS404759: Up regulated genes from putamen (from dorsal striatum) from postmortem human brain tissue with Alcohol Use Disorder (AUD)
Tier IV 10443 GS404760: Down regulated genes from ventral striatum from postmortem human brain tissue with Alcohol Use Disorder (AUD)
Tier IV 18653 GS407376: Dysregulation of NRSF/REST via EHMT1 is associated with psychiatric disorders and Kleefstra syndrome
Tier III 19111 GS407935: Differentially expressed genes in human kidney tumors associated with extended opioid exposure_logFC
Tier III 17086 GS407944: Differentially expressed genes in opioid use disorder postmortem human brain_qvalue
Tier III 17086 GS407945: Differentially expressed genes in opioid use disorder postmortem human brain_log2FC
Tier III 18513 GS407948: Differentially expressed genes in humans nucleus accumbens associated with opioid use disorder_log2FC
Tier III 18278 GS407950: Differentially expressed genes in humans dorsolateral prefrontal cortex associated with opioid use disorder_log2FC
Tier III 19863 GS407964: Differential gene expression in human postmortem tissue samples of the dorsolateral prefrontal cortex_logFC
Tier IV 13854 GS408212: Transcriptional differences in dorsolateral prefrontal cortex (DLPFC) and nucleus accumbens (NAc) in unaffected comparison subjects_coefficient
Tier IV 13854 GS408213: Transcriptional differences in dorsolateral prefrontal cortex (DLPFC) and nucleus accumbens (NAc) in unaffected comparison subjects_qvalue
Tier IV 13854 GS408215: Transcriptional differences in dorsolateral prefrontal cortex (DLPFC) in human opioid use disorder subjects_coefficient
Tier IV 13854 GS408217: Transcriptional differences in nucleus accumbens (NAc) in human opioid use disorder subjects_coefficient
Tier IV 169 GS408222: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_reanalysis of Corradin et al. 2022_log2FC
Tier IV 169 GS408223: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_reanalysis of Corradin et al. 2022_qvalue
Tier IV 87 GS408224: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_reanalysis of Mendez et al 2021_log2FC